New Study for People Carrying the APOL1 AMKD Gene
At ANC, we’re always looking for ways to improve care and bring cutting-edge research to our patients. We recently sat down with Dr. Doyle to talk about an exciting opportunity: the Horizon clinical trial by Maze Therapeutics, a national study focused on addressing genetic kidney disease in Black Americans. What Is the Horizon Trial […]
Join ANC’s Clinical Research Studies: A Path to a Healthier Tomorrow
About 30 years ago several clinical research studies in kidney patients showed that a particular kind of blood pressure medications slowed kidney disease progression. This finding made possible by many patient volunteers who participated in critical drug studies, revolutionized how we have treated kidney disease for the last 30 years. Most kidney patients still take […]
